BioMedNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Medi-Scan Featured in BioWorld(TM) Article

March 29, 2021 14:30:46

Healthtech Solutions’ (OTC: HLTT) subsidiary, Medi-Scan Inc., was featured in a recent BioWorld(TM) article titled, “Medi-Scan’s digital tool converts ultrasound images to 3D at the point of care.” The piece discusses Medi-Scan’s cloud-based software that has the capability to rapidly (in less than two minutes) convert the data on ultrasound analog 2D grayscale images into a digital 3D high-definition (“HD”) format. The company’s efforts currently focus on the heart and lungs, as it aims to provide quick, point-of-service evaluation and triaging of patients with heart disease and other conditions, including those suffering from COVID-19. Medi-Scan’s machine learning-based solution provides clinicians with a portable, hand-held device that connects to their smartphone through a mobile app that includes multiple reporting features and a full, built-in EMR with telehealth capability. “When you’re delivering a 3D image of whatever region you’re focused on, you can do a scan not moving the patient in the ER,” David Rubin, CEO of Medi-Scan, stated in the article. As the patient’s condition progresses over time, “you can walk over with a portable, wireless device and scan the patient and get insights into whether the patient is getting better or worse.”

To view the full article, visit

Healthtech Solutions Inc.

Healthtech Solutions is the parent company of Medi-Scan Inc. and RevHeart Inc. Through its subsidiary, Medi-Scan, the company offers technology that can transform 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The technology has multiple applications in lung, cardiac and musculoskeletal imaging and related uses. For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork